1-20 of 114
Hui Liu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

All- trans retinoic acid plus low-dose rituximab vs low-dose rituximab in corticosteroid-resistant or relapsed ITP

CME Clinical Trials & Observations
Ye-Jun Wu, Hui Liu, Qiao-Zhu Zeng, Yi Liu, Jing-Wen Wang, Wen-Sheng Wang, Jia-Feng, He-Bing Zhou, Qiu-Sha Huang, Yun He, Hai-Xia Fu, Xiao-Lu Zhu, Qian Jiang, Hao Jiang, Ying-Jun Chang, Lan-Ping Xu, Xiao-Jun Huang, Xiao-Hui Zhang
Journal: Blood
Blood (2022) 139 (3): 333–342.
DOI: https://doi.org/10.1182/blood.2021013393
Published: 2022
Includes: Supplemental data
Journal Articles

EBV + ALK + large B-cell lymphoma

Hui Liu, Shimin Hu
Journal: Blood
Blood (2021) 138 (25): 2741.
DOI: https://doi.org/10.1182/blood.2021013595
Published: 2021
Journal Articles

Clinicopathologic Characteristics and Genomic Profiling of De Novo CD5 Positive Diffuse Large B-Cell Lymphoma: A Multicenter Retrospective Study in China

Wei Sang, Yuhan Ma, Xiangmin Wang, Ziyuan Shen, Linyan Xu, Jianlin Qiao, Kailin Xu, Hui Liu
Journal: Blood
Blood (2021) 138 (Supplement 1): 4568.
DOI: https://doi.org/10.1182/blood-2021-149852
Published: 2021
Journal Articles

Safety and Efficacy of CD19 CAR-T Cells Co-Expressing IL-7 and CCL19 in Combination with Anti-PD-1 Antibody for Refractory/Relapsed DLBCL: Preliminary Data from the Phase Ⅰb Trial (NCT04381741)

Wenbin Qian, Aiqi Zhao, Hui Liu, Wen Lei, Yun Liang, Xianggui Yuan
Journal: Blood
Blood (2021) 138 (Supplement 1): 3843.
DOI: https://doi.org/10.1182/blood-2021-144523
Published: 2021
Journal Articles

BRUIN CLL-322: A Phase 3 Open-Label, Randomized Study of Fixed Duration Pirtobrutinib Plus Venetoclax and Rituximab Versus Venetoclax and Rituximab in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (Trial in Progress)

Anthony R. Mato, William G. Wierda, John M. Pagel, Matthew S. Davids, Pier Luigi Zinzani, Yi Lu, Hui Liu, Safi Shahda, Ching Ching Leow, Constantine S. Tam, Jennifer A. Woyach, Toby A. Eyre
Journal: Blood
Blood (2021) 138 (Supplement 1): 3742.
DOI: https://doi.org/10.1182/blood-2021-145936
Published: 2021
Journal Articles

Relmacabtagene Autoleucel CD19 CART Therapy for Adults with Heavily-Pretreated Relapsed/Refractory Large B-Cell Lymphoma in China

Yuqin Song, Zhitao Ying, Haiyan Yang, Ye Guo, Wenyu Li, Dehui Zou, Daobin Zhou, Zhao Wang, Mingzhi Zhang, Jianqiu Wu, Hui Liu, Pian Zhang, Su Yang, Zisong Zhou, Hongxia Zheng, Jun Zhu
Journal: Blood
Blood (2021) 138 (Supplement 1): 3557.
DOI: https://doi.org/10.1182/blood-2021-148358
Published: 2021
Journal Articles

Study of Bone Marrow Mesenchymal Stem Cells Regulating NK Cells Function through Tigit/ CD226 in Patients with Multiple Myeloma

Rong Fu, Ling Deng, Zhaoyun Liu, Hui Liu, Zonghong Shao
Journal: Blood
Blood (2021) 138 (Supplement 1): 2685.
DOI: https://doi.org/10.1182/blood-2021-152389
Published: 2021
Journal Articles

Lenalidomide, Rituximab and Methotrexate（R2-MTX）in Newly Diagnosed Primary Central Nervous System Lymphoma

Xianggui Yuan, Yun Liang, Hui Liu, Yang Xu, Aiqi Zhao, Xiaohua Xu, Wenbin Qian
Journal: Blood
Blood (2021) 138 (Supplement 1): 2491.
DOI: https://doi.org/10.1182/blood-2021-145565
Published: 2021
Journal Articles

SUZ12 Participates in PNH Cloning Proliferation By Regulating Histone H3K27me3 Methylation Level

Rong Fu, Yingying Chen, Zonghong Shao, Hui Liu, Lijie Zeng, Liyan Li, Dan Lu, Zhaoyun Liu
Journal: Blood
Blood (2021) 138 (Supplement 1): 1106.
DOI: https://doi.org/10.1182/blood-2021-148546
Published: 2021
Journal Articles

Lenalidomide Versus Thalidomide or Bortezomib As Maintenance Regimens for Non-Transplant Patients with Multiple Myeloma: Multi-Center Real World Experience in China

Zhe Zhuang, Lei Shi, Ying Tian, Dongmei Zou, Ru Feng, Fei Dong, Yanping Ma, Hong Yu, Wei-wei Tian, Shuangjiao Liu, Liangming Ma, Rong Fu, Hongmei Jing, Hui Liu, Wanling Sun, Chen Wenming, Yin Wu, Li Bao, Junling Zhuang
Journal: Blood
Blood (2021) 138 (Supplement 1): 4728.
DOI: https://doi.org/10.1182/blood-2021-149502
Published: 2021
Journal Articles

Ixazomib Versus Lenalidomide or Ixazomib and Lenalidomide Combination As Maintenance Regimens for Patients with Multiple Myeloma: Interim Analysis of a Multi-Center Prospective Study in China

Zhe Zhuang, Ying Tian, Wei-wei Tian, Hong Yu, Dongmei Zou, Qinhua Liu, Lei Shi, Fei Dong, Yanping Ma, Ru Feng, Shuangjiao Liu, Hui Liu, Hongmei Jing, Li Bao, Wanling Sun, Rong Fu, Liangming Ma, Chen Wenming, Yin Wu, Junling Zhuang
Journal: Blood
Blood (2021) 138 (Supplement 1): 4766.
DOI: https://doi.org/10.1182/blood-2021-152542
Published: 2021
Journal Articles

Trial in Progress: A Perspective Study of Pan-Oral Triplet Regimen Pomalidomide, Ixazomib and Dexamethasone in Relapsed or Refractory Myeloma Patients

Miao Chen, Li Bao, Wenming Chen, Rong Fu, Rong Guo, Hongmei Jing, Hui Liu, Qinhua Liu, Yanping Ma, Xiuli SUN, Wei Wang, Yafei Wang, Xiaojing Yan, Jiang Qian, Junling Zhuang
Journal: Blood
Blood (2021) 138 (Supplement 1): 4783.
DOI: https://doi.org/10.1182/blood-2021-148237
Published: 2021
Journal Articles

Clinical Characteristics, Treatment and Outcome of Patients with Mantle Cell Lymphoma: A Large, Multicenter Retrospective Analysis in China

Ping Yang, Shuozi Liu, Jing Wang, Wei Zhang, Hui Liu, Xiuhua Sun, Yujun Dong, Hongmei Jing
Journal: Blood
Blood (2021) 138 (Supplement 1): 4522.
DOI: https://doi.org/10.1182/blood-2021-149042
Published: 2021
Journal Articles

All-Trans Retinoic Acid Plus Low-Dose Rituximab Vs Low-Dose Rituximab in Corticosteroid-Resistant or Relapsed ITP

Ye-Jun Wu, Hui Liu, Qiao-Zhu Zeng, Yi Liu, Jing-Wen Wang, Wen-Sheng Wang, Jia Feng, He-Bing Zhou, Qiu-Sha Huang, Hai-Xia Fu, Xiao-Lu Zhu, Yun He, Hao Jiang, Ying-Jun Chang, Lan-Ping Xu, Xiao-Jun Huang, Xiao-Hui Zhang
Journal: Blood
Blood (2021) 138 (Supplement 1): 15.
DOI: https://doi.org/10.1182/blood-2021-149527
Published: 2021
Journal Articles

A composite single-nucleotide polymorphism prediction signature for extranodal natural killer/T-cell lymphoma

Clinical Trials & Observations
Xiao-Peng Tian, Shu-Yun Ma, Ken H. Young, Choon Kiat Ong, Yan-Hui Liu, Zhi-Hua Li, Qiong-Li Zhai, Hui-Qiang Huang, Tong-Yu Lin, Zhi-Ming Li, Zhong-Jun Xia, Li-Ye Zhong, Hui-Lan Rao, Mei Li, Jun Cai, Yu-Chen Zhang, Fen Zhang, Ning Su, Peng-Fei Li, Feng Zhu, Zijun Y. Xu-Monette, Esther Kam Yin Wong, Jeslin Chian Hung Ha, Lay Poh Khoo, Le Ai, Run-Fen Cheng, Jing Quan Lim, Sanjay de Mel, Siok-Bian Ng, Soon Thye Lim, Qing-Qing Cai
Journal: Blood
Blood (2021) 138 (6): 452–463.
DOI: https://doi.org/10.1182/blood.2020010637
Published: 2021
Includes: Supplemental data
Journal Articles

Bone Marrow-Derived Mesenchymal Stem Cells Inhibit CD8 + t Cell Immune Responses Via PD-1/PD-L1 Pathway in Multiple Myeloma

Zhaoyun Liu, Fu Mi, Mei Han, Mengyue Tian, PhD, Hui Liu, Rong Fu, PhD, Zonghong Shao, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 53–54.
DOI: https://doi.org/10.1182/blood-2020-138418
Published: 2020
Journal Articles

The Study of Proliferation Relative Long Non-Coding RNA FAM157C in CD59 - cell from Paroxysmal Nocturnal Hemoglobinuria Patients

Honglei Wang, Rong Fu, PhD, Hui Liu, Zhaoyun Liu, Liyan Li, Yingying Chen, Zonghong Shao, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 33–34.
DOI: https://doi.org/10.1182/blood-2020-139252
Published: 2020
Journal Articles

Clinical Response of CD19 CAR-T Cells (relmacabtagene autoleucel, relma-cel) in Adults with Heavily-Pre-Treated Relapsed/Refractory (r/r) Large B-Cell Lymphoma in China

Jun Zhu, MD, Zhitao Ying, MD, Yuqin Song, MD PhD, Haiyan Yang, MD PhD, Ye Guo, MD, Wenyu Li, PhD, Dehui Zou, MD, Daobin Zhou, MD PhD, Zhao Wang, MD, Mingzhi Zhang, MD, Jianqiu Wu, MD, Hui Liu, MD, Pian Zhang, Su Yang, Zisong Zhou, Hongxia Zheng, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 39–40.
DOI: https://doi.org/10.1182/blood-2020-136038
Published: 2020
Journal Articles

Gls-010, a Novel Anti-PD-1 Mab in Chinese Patients with Relapsed or Refractory Classical Hodgkin Lymphoma: Preliminary Impressive Results of a Phase II Clinical Trial

Yuqin Song, MD PhD, Jun Zhu, BS, Ningjing Lin, MD PhD, Mingzhi Zhang, MD, Hai Bai, MD, Hui Liu, MD, Jie Cui, MD, Xiaoyan Ke, MD, Huilai Zhang, MD PhD, Lihong Liu, MD, Dongmei Yan, MD, Yongsheng Jiang, MD, Aimin Zang, MD, Junyuan Qi, MD, Li Wang, MD, Zhuogang Liu, MD, Bing Xu, MD PhD, Ying Zhang, MD, Zhihui Zhang, MD PhD, Haijin Meng, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 17.
DOI: https://doi.org/10.1182/blood-2020-136475
Published: 2020
Journal Articles

Combination of Homoharringtonine with Venetoclax and Azacitidine Excerts Better Treatment Response in Relapsed /Refractory Acute Myeloid Leukemia

Guopan Yu, Na Xu, Fen Huang, Zhiping Fan, MD, Hui Liu, Pengcheng Shi, Hongsheng Zhou, MD PhD, Zhixiang Wang, Yu Zhang, Qifa Liu, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 26–27.
DOI: https://doi.org/10.1182/blood-2020-138676
Published: 2020